Michael Keeley

Partner at Axinn

Speaker

Mike Keeley, chair of Axinn, Veltrop & Harkrider’s antitrust practice, has 30 years of experience guiding clients through antitrust clearance for multibillion-dollar mergers, trying complex antitrust cases, and guiding companies through today’s increasingly challenging antitrust landscape. Under Mike’s leadership, the Axinn antitrust practice has grown to be the largest in the United States.

His strategic transactions work includes advising on major deals like Take-Two Interactive Software Inc.‘s $13 billion acquisition of Zynga, Dell Technologies Inc.‘s $67 billion acquisition of EMC Corporation, Choice Hotels International, Inc., in its proposed $8 billion acquisition of Wyndham Hotels & Resorts, and Thermo Fisher Scientific Inc.’s $13.6 billion acquisition of Life Technologies.

Where mergers have been challenged, Mike has tried and prevailed in multiple cases, including the U.S. Department of Justice (DOJ) Antitrust Division’s challenge to the sale of Tyson Foods’ poultry processing complex to George’s Inc., as well as the City of New York’s challenge to the combination of health insurers Group Health Incorporated (GHI) and Health Insurance Plan of Greater New York (HIP) to form EmblemHealth.